Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

mcr-1 gene found in beef sample - FSA
Scientists purchased 314 beef and 310 pork samples from retail premises in England, Scotland, Wales and Northern Ireland.
Overall levels of AMR E. coli in UK retail meat ‘remain low’ 

A beef sample that tested positive for E. coli has been found to contain the mcr-1 gene that confers resistance to the antibiotic colistin.

The Food Standards Agency (FSA) said it is thought to be the first discovery of mcr-1 positive E. coli from retail beef in the UK; but stressed that the risk to public health is very low.

Now in its third year, the EU survey found the levels of antimicrobial resistant (AMR) E. coli in raw UK pork and beef remain consistently low. Scientists purchased 314 beef and 310 pork samples from retail premises in England, Scotland, Wales and Northern Ireland.

Overall, less than one per cent of the samples were positive for ESBL or AmpC E. Coli, which is similar to findings from year one of the survey. However, one beef sample was contaminated with an E. coli containing the mcr-1 gene.

The gene is found on a plasmid, which is naturally able to pass from one bacterial cell to another, allowing AMR to spread more easily. It can also make bacteria resistant to colistin, a ‘last resort’ antibiotic.

Paul Cook, FSA’s head of microbiological risk assessment, said: “This is thought to be the first discovery of an mcr-1 positive E. coli from retail beef in the UK.

“Although the meat came from outside the UK, further testing indicated no contamination with this E.coli on other samples and at this stage we have not been able to pinpoint the source of the contamination.

“However, a risk assessment has been carried out and we want to make it clear that the risk to public health is very low.”  

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.